IBDEI0T7 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14409,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,14410,0)
 ;;=272.0^^89^892^55
 ;;^UTILITY(U,$J,358.3,14410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14410,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,14410,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,14410,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,14411,0)
 ;;=272.1^^89^892^58
 ;;^UTILITY(U,$J,358.3,14411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14411,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,14411,1,5,0)
 ;;=5^Hypertriglyceridemia
 ;;^UTILITY(U,$J,358.3,14411,2)
 ;;=Hypertriglyceridemia^101303
 ;;^UTILITY(U,$J,358.3,14412,0)
 ;;=272.2^^89^892^63
 ;;^UTILITY(U,$J,358.3,14412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14412,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,14412,1,5,0)
 ;;=5^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,14412,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,14413,0)
 ;;=396.0^^89^892^11
 ;;^UTILITY(U,$J,358.3,14413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14413,1,4,0)
 ;;=4^396.0
 ;;^UTILITY(U,$J,358.3,14413,1,5,0)
 ;;=5^Aortic and Mitral Stenosis
 ;;^UTILITY(U,$J,358.3,14413,2)
 ;;=Aortic and Mitral Stenosis^269580
 ;;^UTILITY(U,$J,358.3,14414,0)
 ;;=414.02^^89^892^18
 ;;^UTILITY(U,$J,358.3,14414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14414,1,4,0)
 ;;=4^414.02
 ;;^UTILITY(U,$J,358.3,14414,1,5,0)
 ;;=5^CAD, Occlusion of Venous Graft
 ;;^UTILITY(U,$J,358.3,14414,2)
 ;;=CAD, Occlusion of Venous Graft^303282
 ;;^UTILITY(U,$J,358.3,14415,0)
 ;;=459.10^^89^892^73
 ;;^UTILITY(U,$J,358.3,14415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14415,1,4,0)
 ;;=4^459.10
 ;;^UTILITY(U,$J,358.3,14415,1,5,0)
 ;;=5^Post Phlebotic Syndrome
 ;;^UTILITY(U,$J,358.3,14415,2)
 ;;=Post Phlebotic Syndrome^328597
 ;;^UTILITY(U,$J,358.3,14416,0)
 ;;=428.20^^89^892^50
 ;;^UTILITY(U,$J,358.3,14416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14416,1,4,0)
 ;;=4^428.20
 ;;^UTILITY(U,$J,358.3,14416,1,5,0)
 ;;=5^Heart Failure, Systolic, Unspec
 ;;^UTILITY(U,$J,358.3,14416,2)
 ;;=Heart Failure, Systolic^328594
 ;;^UTILITY(U,$J,358.3,14417,0)
 ;;=428.21^^89^892^42
 ;;^UTILITY(U,$J,358.3,14417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14417,1,4,0)
 ;;=4^428.21
 ;;^UTILITY(U,$J,358.3,14417,1,5,0)
 ;;=5^Heart Failure, Acute Systolic
 ;;^UTILITY(U,$J,358.3,14417,2)
 ;;=Heart Failure, Acute Systolic^328494
 ;;^UTILITY(U,$J,358.3,14418,0)
 ;;=428.22^^89^892^44
 ;;^UTILITY(U,$J,358.3,14418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14418,1,4,0)
 ;;=4^428.22
 ;;^UTILITY(U,$J,358.3,14418,1,5,0)
 ;;=5^Heart Failure, Chronic Systolic
 ;;^UTILITY(U,$J,358.3,14418,2)
 ;;=Heart Failure, Chronic Systolic^328495
 ;;^UTILITY(U,$J,358.3,14419,0)
 ;;=428.23^^89^892^49
 ;;^UTILITY(U,$J,358.3,14419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14419,1,4,0)
 ;;=4^428.23
 ;;^UTILITY(U,$J,358.3,14419,1,5,0)
 ;;=5^Heart Failure, Systolic, Acute on Chronic
 ;;^UTILITY(U,$J,358.3,14419,2)
 ;;=Heart Failure, Systolic, Acute on Chronic^328496
 ;;^UTILITY(U,$J,358.3,14420,0)
 ;;=428.30^^89^892^45
 ;;^UTILITY(U,$J,358.3,14420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14420,1,4,0)
 ;;=4^428.30
 ;;^UTILITY(U,$J,358.3,14420,1,5,0)
 ;;=5^Heart Failure, Diastolic
 ;;^UTILITY(U,$J,358.3,14420,2)
 ;;=Heart Failure, Diastolic^328595
 ;;^UTILITY(U,$J,358.3,14421,0)
 ;;=428.31^^89^892^41
 ;;^UTILITY(U,$J,358.3,14421,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14421,1,4,0)
 ;;=4^428.31
 ;;^UTILITY(U,$J,358.3,14421,1,5,0)
 ;;=5^Heart Failure, Acute Diastolic
 ;;^UTILITY(U,$J,358.3,14421,2)
 ;;=Heart Failure, Acute Diastolic^328497
 ;;^UTILITY(U,$J,358.3,14422,0)
 ;;=428.32^^89^892^43
